This follows Sun Pharma's recent recall of 54,960 bottles of Mesalamine extended-release capsules in the American market. Mesalamine delayed-release capsules are indicated for the treatment of ...

India’s Sun Pharma has signed an agreement to take full control of Israeli generic drugmaker Taro Pharmaceutical Industries, taking it into private hands. New York Stock Exchange (NYSE)-listed ...

Sun Pharmaceutical Industries Ltd. closed 16.18% short of its 52-week high of 1,960.20 rupees, which the company reached on ...

In the same year, Sun Pharma opened its first manufacturing facility for the production of tablets and capsules at Vapi, Gujarat, India. Initially, the company manufactured five psychiatry products.

The launch timeline of Sun Pharma's specialty drug Leqselvi (deuruxolitinib) continues to be stuck in a limbo even after two quarters since it got embroiled in a patent dispute. The drug ...

Sun Pharmaceutical Industries Ltd. closed 14.82% short of its 52-week high of 1,960.20 rupees, which the company reached on ...